Clinical significance of atypical glandular cells on Pap smears: Experience from a region with a high incidence of cervical cancer

Aim: To evaluate the histopathology of women who had atypical glandular cells (AGC) on Pap smears in a region with high incidence of cervical cancer. Material and Methods: This study was conducted at Chiang Mai University Hospital, Chiang Mai, Thailand. All women with AGC who underwent colposcopic a...

Full description

Saved in:
Bibliographic Details
Main Authors: Sawangsang P., Sae-Teng C., Suprasert P., Srisomboon J., Khunamornpong S., Kietpeerakool C.
Format: Review
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-80052742598&partnerID=40&md5=cd639f8aa2fb720a623f04b185cc413e
http://www.ncbi.nlm.nih.gov/pubmed/21159042
http://cmuir.cmu.ac.th/handle/6653943832/3015
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-3015
record_format dspace
spelling th-cmuir.6653943832-30152014-08-30T02:25:39Z Clinical significance of atypical glandular cells on Pap smears: Experience from a region with a high incidence of cervical cancer Sawangsang P. Sae-Teng C. Suprasert P. Srisomboon J. Khunamornpong S. Kietpeerakool C. Aim: To evaluate the histopathology of women who had atypical glandular cells (AGC) on Pap smears in a region with high incidence of cervical cancer. Material and Methods: This study was conducted at Chiang Mai University Hospital, Chiang Mai, Thailand. All women with AGC who underwent colposcopic and histopathologic evaluation between January 2002 and December 2008 were reviewed. Women with simultaneous diagnosis of squamous cell abnormality or prior history of cancer of any type were excluded. Results: Sixty-three women with AGC Pap test had histologic follow-up during the study period. Mean age was 44.9 years (range, 31-72 years). Six (9.5%) women were nulliparous. Sixteen (25.4%) women were postmenopausal. The histopathologic results of these 63 women were as follows: cervical intraepithelial neoplasia (CIN) 2-3, 5 (7.9%); adenocarcinoma in situ (AIS), 3 (4.8%); endometrial cancer, 3 (4.8%); cervical cancer, 2 (3.2%); endometrial hyperplasia (EH), 1 (1.6%); and no lesions, 49 (77.8%). The prevalence of significant lesions (CIN 2-3, AIS, EH, and cancer) in women with atypical glandular cells, favor neoplasia (AGC-FN) was significantly higher than that in the atypical glandular cells, not other specified (AGC-NOS) group (41.2% and 15.2%, P = 0.02). Conclusion: Reporting AGC in our population is clinically significant due to the high prevalence of underlying preinvasive and invasive diseases (22.2%). This subtype of the AGC category is a significant predictor of such lesions. © 2010 The Authors. 2014-08-30T02:25:39Z 2014-08-30T02:25:39Z 2011 Review 13418076 10.1111/j.1447-0756.2010.01387.x JOGRF http://www.scopus.com/inward/record.url?eid=2-s2.0-80052742598&partnerID=40&md5=cd639f8aa2fb720a623f04b185cc413e http://www.ncbi.nlm.nih.gov/pubmed/21159042 http://cmuir.cmu.ac.th/handle/6653943832/3015 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description Aim: To evaluate the histopathology of women who had atypical glandular cells (AGC) on Pap smears in a region with high incidence of cervical cancer. Material and Methods: This study was conducted at Chiang Mai University Hospital, Chiang Mai, Thailand. All women with AGC who underwent colposcopic and histopathologic evaluation between January 2002 and December 2008 were reviewed. Women with simultaneous diagnosis of squamous cell abnormality or prior history of cancer of any type were excluded. Results: Sixty-three women with AGC Pap test had histologic follow-up during the study period. Mean age was 44.9 years (range, 31-72 years). Six (9.5%) women were nulliparous. Sixteen (25.4%) women were postmenopausal. The histopathologic results of these 63 women were as follows: cervical intraepithelial neoplasia (CIN) 2-3, 5 (7.9%); adenocarcinoma in situ (AIS), 3 (4.8%); endometrial cancer, 3 (4.8%); cervical cancer, 2 (3.2%); endometrial hyperplasia (EH), 1 (1.6%); and no lesions, 49 (77.8%). The prevalence of significant lesions (CIN 2-3, AIS, EH, and cancer) in women with atypical glandular cells, favor neoplasia (AGC-FN) was significantly higher than that in the atypical glandular cells, not other specified (AGC-NOS) group (41.2% and 15.2%, P = 0.02). Conclusion: Reporting AGC in our population is clinically significant due to the high prevalence of underlying preinvasive and invasive diseases (22.2%). This subtype of the AGC category is a significant predictor of such lesions. © 2010 The Authors.
format Review
author Sawangsang P.
Sae-Teng C.
Suprasert P.
Srisomboon J.
Khunamornpong S.
Kietpeerakool C.
spellingShingle Sawangsang P.
Sae-Teng C.
Suprasert P.
Srisomboon J.
Khunamornpong S.
Kietpeerakool C.
Clinical significance of atypical glandular cells on Pap smears: Experience from a region with a high incidence of cervical cancer
author_facet Sawangsang P.
Sae-Teng C.
Suprasert P.
Srisomboon J.
Khunamornpong S.
Kietpeerakool C.
author_sort Sawangsang P.
title Clinical significance of atypical glandular cells on Pap smears: Experience from a region with a high incidence of cervical cancer
title_short Clinical significance of atypical glandular cells on Pap smears: Experience from a region with a high incidence of cervical cancer
title_full Clinical significance of atypical glandular cells on Pap smears: Experience from a region with a high incidence of cervical cancer
title_fullStr Clinical significance of atypical glandular cells on Pap smears: Experience from a region with a high incidence of cervical cancer
title_full_unstemmed Clinical significance of atypical glandular cells on Pap smears: Experience from a region with a high incidence of cervical cancer
title_sort clinical significance of atypical glandular cells on pap smears: experience from a region with a high incidence of cervical cancer
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-80052742598&partnerID=40&md5=cd639f8aa2fb720a623f04b185cc413e
http://www.ncbi.nlm.nih.gov/pubmed/21159042
http://cmuir.cmu.ac.th/handle/6653943832/3015
_version_ 1681419968633110528